Publication Name	World Journal of Clinical Oncology
Manuscript ID	85445
Country	China

Received	2023-04-28 10:49
Peer-Review Started	2023-04-28 10:51
To Make the First Decision
Return for Revision	2023-07-28 08:36
Revised	2023-08-05 13:30
Second Decision	2023-09-04 02:53
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2023-09-04 08:52
Articles in Press	2023-09-04 08:52
Publication Fee Transferred
Edit the Manuscript by Language Editor	2023-09-01 13:44
Typeset the Manuscript	2023-09-17 09:45
Publish the Manuscript Online	2023-09-20 04:15

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Oncology
Manuscript Type	Minireviews
Article Title	Progress in the research of cuproptosis and possible targets for cancer therapy
Manuscript Source	Invited Manuscript
All Author List	Jiang Wang, Lan-Zhu Luo, Dao-Miao Liang, Chao Guo, Zhi-Hong Huang, Guo-Ying Sun and Jie Wen
ORCID	Author(s) ORCID Number Jiang Wang http://orcid.org/0000-0002-2036-1263 Jie Wen http://orcid.org/0000-0002-5734-4678
Funding Agency and Grant Number	Funding Agency Grant Number Scientific Research Project of Hunan Education Department No. 21A0054
Corresponding Author	Jie Wen, PhD, Associate Professor, Department of Pediatric Orthopedics, Hunan Provincial People’s Hospital, the First Affiliated Hospital of Hunan Normal University, No. 61 West Jiefang Rd, Changsha 410013, Hunan Province, China. cashwj@qq.com
Key Words	Cuproptosis; Cuproptosis-related genes; Cancer; Targeted therapy
Core Tip	Developing novel cancer therapies that exploit programmed cell death pathways holds promise for advancing cancer treatment. Cuproptosis-related genes were identified by Tsvetkov, including ferredoxin 1, lipoic acid synthase, lipoyltransferase 1, dihydrolipid amide dehydrogenase, dihydrolipoamide transacetylase, pyruvate dehydrogenase a1, pyruvate dehydrogenase b, metallothionein, glutaminase, and cyclin-dependent kinase inhibitor 2A. Here, we provide a new understanding of the role of copper death and related genes in cancer.
Publish Date	2023-09-20 04:15
Citation	Wang J, Luo LZ, Liang DM, Guo C, Huang ZH, Sun GY, Wen J. Progress in the research of cuproptosis and possible targets for cancer therapy. World J Clin Oncol 2023; 14(9): 324-334
URL	https://www.wjgnet.com/2218-4333/full/v14/i9/324.htm
DOI	https://dx.doi.org/10.5306/wjco.v14.i9.324

Full Article (PDF)	WJCO-14-324-with-cover.pdf
Full Article (Word)	WJCO-14-324.docx
Manuscript File	85445_Auto_Edited-XLQ-Kerr C-JLW.docx
Answering Reviewers	85445-Answering reviewers.pdf
Audio Core Tip	85445-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	85445-Conflict-of-interest statement.pdf
Copyright License Agreement	85445-Copyright license agreement.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	85445-Grant application form(s).pdf
Non-Native Speakers of English Editing Certificate	85445-Language certificate.pdf
Peer-review Report	85445-Peer-review(s).pdf
Scientific Misconduct Check	85445-Bing-Qu XL-2.png
Scientific Editor Work List	85445-Scientific editor work list.pdf